EMAIL: mattl@mjbizdaily.com
PHONE: 720.699.0794

Matt Lamers

Matt is based in the Greater Toronto Area and covers international cannabis markets for Marijuana Business Daily. Previously, he worked as a business editor, photographer and reporter for newspapers and magazines in three countries, covering everything from the oil and gas industry in northern British Columbia to North Korean defectors in Seoul.

Canadian marijuana firm Canopy Growth files $2 billion shelf prospectus

Canadian marijuana producer Canopy Growth filed a preliminary short-form base shelf prospectus enabling the company to raise up to $2 billion (2.5 billion Canadian dollars) in one or more series or issuances of securities over a 25-month period. It is believed to be the largest shelf prospectus by a cannabis company. The move also signals […]

Read More

Aurora says its Danish cannabis has reached German pharmacies

A subsidiary of Canada’s Aurora Cannabis says its “made in Denmark” medical cannabis products have reached some Germany pharmacies for the first time – a milestone that was years in the making. The German distribution comes before the products have been cleared by authorities for sale in Denmark, where the medicine is produced. It’s the […]

Read More

Green Organic Dutchman weighs sale of cannabis greenhouse in Quebec

The Green Organic Dutchman is considering the sale of its mammoth cannabis greenhouse in Salaberry-de-Valleyfield, Quebec, only about two months after the Mississauga, Ontario-based licensed producer increased its stake in the property to 100%. “Multiple bids are being considered, and the transaction could result in a complete or partial sale of the site,” the company […]

Read More

How a $100M global cannabis deal came together over Zoom: Q&A with IMC’s Oren Shuster

Negotiating an international cannabis merger worth roughly $100 million is hard enough – but doing so during a global pandemic is downright daunting. That’s what Israel’s IM Cannabis had to do when it agreed in late 2020 to acquire Toronto-headquartered Trichome Financial, a specialty finance company serving cannabis companies. Because of the coronavirus pandemic, global […]

Read More

Canadian marijuana producer Tilray reports $271 million loss for year

Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million loss in 2019, according to the full-year and fourth-quarter results released Wednesday. Tilray, which is on the verge of being merged with Canadian peer Aphria, lost only $3 million in its fourth quarter […]

Read More

Canopy unloads British Columbia cannabis greenhouses at large loss

Smiths Falls, Ontario-based Canopy Growth sold off two facilities in British Columbia that it once touted as the largest cannabis greenhouses in the world. In a regulatory filing this week, the company said it completed the sale of its production facilities in Aldergrove and Delta in December and January, respectively, for a combined 40.6 million […]

Read More

Aurora reports lower sales of adult-use cannabis

Aurora Cannabis sold less adult-use marijuana in its second quarter of 2021 compared to the previous quarter, but that was partially offset by growing revenue from its medical business, the Alberta-based company reported Thursday. Recreational cannabis net revenue was 28.6 million Canadian dollars ($22.5 million) for the quarter ended Dec. 31, 2020, 17% lower than […]

Read More

Health Canada declines to fine cannabis companies for violations, opting for other penalties

Canada’s top cannabis regulator chose not to fine CannTrust and Bonify Medical Cannabis despite significant violations of the rules governing the country’s marijuana industry – including illegal cultivation and sale. In fact, Health Canada has not issued fines – known as administrative monetary penalties – to any cannabis business since recreational legalization in late 2018, […]

Read More

Australia to ‘significantly reduce’ regulatory burden for cannabis industry

Australia has proposed amendments to the Narcotic Drugs Act that would overhaul the medical cannabis industry by streamlining the licensing process for businesses and ensure access for patients. Rhys Cohen, editor-at-large for the Australian publication Cannabiz, said the measures will allow companies to operate more efficiently and flexibly if fully implemented. “For foreign businesses, it […]

Read More

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis producers benefiting, only businesses that have marketable intellectual property and an established foothold in the medical cannabinoid arena will draw serious […]

Read More

Legal recreational cannabis sales in Canada outstrip illicit spending for first time

Sales of regulated adult-use cannabis in Canada overtook illegal transactions for the first time in the third quarter of 2020, according to new Statistics Canada data. That development demonstrates the success of legalization in these early years, experts say, though more needs to be done regarding taxes and promotions rules to put the regulated industry […]

Read More